Abstract: The present invention relates to a water treatment device, and more specifically to a water purifier capable of removing scale in a simple manner.

Abstract: A free motion headform (FMH) impact performance prediction device using artificial intelligence includes a data processing processor configured to generate an image by extracting a pre-processed test target image, generated by pre-processing test target design data, using a pre-trained model and generate a pre-processed test target distance value by pre-processing the test target design data. The FMH input performance prediction device also includes a machine learning processor configured to concatenate the image generated by extraction on the basis of the pre-trained model and the pre-processed test target distance value and to predict impact performance using a neural network in which parameters are updated by learning based on an image obtained by pre-processing existing design data and existing impact amount data corresponding to the existing design data. The FMH input performance prediction device further includes an output processor configured to output a value learned by the machine learning processor.

Abstract: Disclosed is a high voltage output device having a serial-parallel stack structure of capacitors. The high voltage output device includes a substrate includes a capacitor element and a pillar structure provided on an upper surface of the substrate. The substrate includes a first electrode and a second electrode, which have different potentials from each other. The capacitor element is connected to at least one of the first electrode and the second electrode.

Abstract: A system and a method which are capable of: collecting packets on a network so as to generate a flow and a session in stages; performing a traffic inspection by using only a small number of packets on the basis of the generated information; and searching packets at a high speed while reducing storage capacity of a packet.

Abstract: The present invention relates to a stabilized external preparation comprising thymosin beta 4 (T?4) as an active ingredient. More specifically, the present invention relates to a therapeutically effective external preparation with improved stability and biological activity of T?4. The preparation according to the present invention provides T?4 in a stable state by maintaining the biological activity of T?4 and minimizing the generation of T?4 sulfoxide through oxidization reactions and multimers through aggregation.

Abstract: A system and a method which are capable of: collecting packets on a network so as to generate a flow and a session in stages; performing a traffic inspection by using only a small number of packets on the basis of the generated information; and searching packets at a high speed while reducing storage capacity of a packet.

Abstract: A network security system performing adaptive rule-set setting, and a method therefor. The network security method includes: a step of performing a trespass detection or prevention process to detect a security threat according to a preset applicable security rule-set among a plurality of packets that a network security system receives from a network, or to enable only a permitted packet to pass, and a packet storage process to selectively store at least a part of the plurality of packets; and a step in which the network security system changes the applicable security rule-set to be applied to the trespass detection or prevention process from a first security so rule-set to a second security rule-set on the basis of the stored packets stored through the packet storage process.

Abstract: The present invention relates to a method for manufacturing an ophthalmic preparation comprising thymosin ?4. According to the inventive method, the manufacture of an ophthalmic preparation comprising thymosin ?4 is carried out in the presence of an inert gas, thus the contact of thymosin ?4 with oxygen is blocked and the oxidation of thymosin ?4 can be prevented and the pharmacological activity of thymosin ?4 maintains for long-term period. Therefore, the ophthalmic preparation prepared by the inventive method can maintain the pharmacological activity of thymosin ?4 in a stable state for a long time.

Abstract: Provided is a semi-automatic air gun that is capable of allowing a hammer to be loaded at the same time when pellets are fired, with a portion of the compressed air discharged from a compressed air tank so as to fire the bullets, so that the hammer and a pellet loading unit move horizontally together to permit the loading and firing of the pellets to be carried out in a semi-automatic manner, thereby making it simple in configuration and obtaining a remarkably excellent compressed air use efficiency.

Abstract: The present invention relates to a therapeutic agent for ophthalmic disease containing thymosin beta 4. The present invention is more effective in reducing xerophthalmia than an ophthalmic solution containing cyclosporine A, is less irritant to eyes than conventional ophthalmic solutions and is physiochemically safe.

Abstract: Provided is a semi-automatic air gun that is capable of allowing a hammer to be loaded at the same time when pellets are fired, with a portion of the compressed air discharged from a compressed air tank so as to fire the bullets, so that the hammer and a pellet loading unit move horizontally together to permit the loading and firing of the pellets to be carried out in a semi-automatic manner, thereby making it simple in configuration and obtaining a remarkably excellent compressed air use efficiency.

Abstract: The present invention relates to a stabilized external preparation comprising thymosin beta 4 (T?4) as an active ingredient. More specifically, the present invention relates to a therapeutically effective external preparation with improved stability and biological activity of T?4. The preparation according to the present invention provides T?4 in a stable state by maintaining the biological activity of T?4 and minimizing the generation of T?4 sulfoxide through oxidization reactions and multimers through aggregation.

Abstract: The present invention relates to a method for manufacturing an ophthalmic preparation comprising thymosin ?4. According to the inventive method, the manufacture of an ophthalmic preparation comprising thymosin ?4 is carried out in the presence of an inert gas, thus the contact of thymosin ?4 with oxygen is blocked and the oxidation of thymosin ?4 can be prevented and the pharmacological activity of thymosin ?4 maintains for long-term period. Therefore, the ophthalmic preparation prepared by the inventive method can maintain the pharmacological activity of thymosin ?4 in a stable state for a long time.

Abstract: A semiconductor device includes a substrate, a two-dimensional (2D) material layer formed on the substrate and having a first region and a second region adjacent to the first region, and a source electrode and a drain electrode provided to be respectively in contact with the first region and the second region of the 2D material layer, the second region of the 2D material layer including an oxygen adsorption material layer in which oxygen is adsorbed on a surface of the second region.

Abstract: The present invention relates to a therapeutic agent for ophthalmic disease containing thymosin beta 4. The present invention is more effective in reducing xerophthalmia than an ophthalmic solution containing cyclosporine A, is less irritant to eyes than conventional ophthalmic solutions and is physiochemically safe.

Abstract: A demand response apparatus receives from a supply resource utilizing apparatus a signal indicating whether power supply from the demand response apparatus to the supply resource utilizing apparatus is possible, estimates a first power usage of the demand response apparatus for a first time interval, changes an operation of the demand response apparatus, estimates a second power usage for a second time interval after the changing of the operation of the demand response apparatus, calculates supply power available to the supply resource utilizing apparatus based on the estimated first power usage and the estimated second power usage, and transmits information about the available supply power to the supply resource utilizing apparatus.

Abstract: The present disclosure relates to a composition for promoting immune activity including a protein selected from the group consisting of dimeric proinsulin, C-peptide partially deleted mutant of dimeric proinsulin, and C-peptide partially deleted mutant of monomeric proinsulin as an effective component and a composition for immunosuppression including C-peptide site of proinsulin as an effective component, and the dimeric proinsulin, the C-peptide partially deleted mutant of dimeric proinsulin, and the C-peptide partially deleted mutant of monomeric proinsulin can be applied as immune enhancers to diabetic patients.

Abstract: A semiconductor device includes a substrate, a two-dimensional (2D) material layer formed on the substrate and having a first region and a second region adjacent to the first region, and a source electrode and a drain electrode provided to be respectively in contact with the first region and the second region of the 2D material layer, the second region of the 2D material layer including an oxygen adsorption material layer in which oxygen is adsorbed on a surface of the second region.

Abstract: An apparatus and method for collecting power from distributed power supply resources are provided. The method includes transmitting a signal for inquiring whether supply of demand-side power supply resources is possible to a providing side that provides demand-side power supply resources, selecting demand-side power supply resources to be utilized, based on power supply resource-related information for each of available demand-side power supply resources, which is received from the providing side, and notifying the selection results to the selected demand-side power supply resources.

Abstract: The present invention relates to sheets. The sheets include an adhesive layer, a base layer formed on the adhesive layer, a resin layer formed on the base layer, and a printed layer formed on the resin layer. Each of the adhesive layer and the resin layer includes a polylactic acid (PLA) resin. The sheets are biodegradable.